Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
An overview of Which Crypto Has Broader Use Cases, weighing ecosystem breadth, developer activity, and practical adoption in finance and tech.
28,483 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Richtech Robotics faced a dramatic sell-off last month as legal issues and a disappointing earnings report rattled in...
Itron stock is making big moves this week, with investors buzzing about quarterly results and smart-city demand. This...
Alibaba heads into 2026 with two clear catalysts. This analysis lays out the two big predictions, explains why they c...
AI stocks are creating big opportunities, but a broad tech ETF like Vanguard's flagship tech might not deliver your A...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Micron stock has surged on AI tailwinds, but powerful under-the-radar forces could extend the rally. This article exp...
Nvidia sits at the heart of AI accelerators and data centers, driving big price targets. This guide explains whether ...
When memory and storage costs rise, Apple often responds with price shifts. This article explains how those moves aff...
SpaceX is redefining its business beyond rocket launches. This article explains the spacex made huge pivot, what it c...
Stocks wobbled as a memory-chip selloff led by South Korea dragged down Micron and peers. This article breaks down wh...
This week brought a notable pullback in AI hardware names, including CoreWeave. Read a clear, practical look at what ...